Manufacturer: Cipla manufactures RALISTA.


The uses of RALISTA include:
Raloxifene is used for: Treating and preventing osteoporosis (bone thinning) in women past menopause.

Ralista is prescribed to treat and prevent osteoporosis, the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you, the greater your chances of developing the disease. These factors include:

Caucasian or Asian descent

Slender build

Early menopause



A diet low in calcium

An inactive lifestyle

Osteoporosis in the family

Raloxifene affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue.

Raloxifene is used to treat or prevent osteoporosis in postmenopausal women. Raloxifene is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer.